Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the treatment of lung cancer in early trials.

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.

FDA grants priority review to Jemperli after a trial shows yearlong disappearance of rectal tumors.

Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3,

University of Missouri researchers have discovered a new way to harness one of the body's natural defenses: copper. While copper is essential for life and helps power important biological processes, having too much of it can be toxic.

The University of Iowa is hoping to launch a new cancer drug institute to address the state's high cancer incidence rates.